Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorŞen Oran, Ebru
dc.contributor.authorGürdal, Sibel Özkan
dc.contributor.authorYankol, Yücel
dc.contributor.authorÖznur, Meltem
dc.contributor.authorCalay, Zerrin
dc.contributor.authorTunacı, Mehtap
dc.contributor.authorSoybir, Gürsel Remzi
dc.date.accessioned2022-05-11T14:12:30Z
dc.date.available2022-05-11T14:12:30Z
dc.date.issued2013
dc.identifier.issn1075-122X
dc.identifier.issn1524-4741
dc.identifier.urihttps://doi.org/10.1111/tbj.12123
dc.identifier.urihttps://hdl.handle.net/20.500.11776/5578
dc.description.abstractIdiopathic granulomatous mastitis (IGM) is a rare, benign, chronic inflammatory condition of the breast, which usually mimics breast carcinoma. The aim of this study was to analyze the clinical features of IGM by identifying a more reliable diagnostic protocol, and evaluating the treatment methods and patient outcomes on follow-up. We performed a retrospective analysis of 46 patients diagnosed with IGM and managed by the same surgical team between 1999 and 2011, at three high-volume hospitals. The median age of the patients was 33years. The most common symptom was painful breast mass (n=39), followed by abscess (n=11). All patients underwent ultrasonography (USG). Mammography (MG) and magnetic resonance imaging (MRI) were also performed in 20 patients (43%) and 17 patients (37%), respectively. The mean size of the lesions was 32.8 +/- 8.8mm and ranged from 15 to 50mm. Preoperative diagnosis of IGM was established by core needle biopsy (CNB) under USG guidance. Eighteen patients (39%) underwent complete excision of the lesion and 25 (54%) were treated with steroids. Three patients treated with steroids subsequently underwent local excision. The mean follow-up period was 35.4 +/- 30.9months. Eight patients (17%) developed disease recurrence; three of these were successfully treated with steroids, one with surgery, and four with both steroids and surgery. CNB in conjunction with high diagnostic accuracy has a significant role in distinctive diagnosis of IGM and hence, is useful for treatment planning. Treatment can be designated according to the extent and the severity of the disease, and the patient's general health and treatment preferences. Patients with IGM must be closely followed up due to the frequency of disease recurrence.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.identifier.doi10.1111/tbj.12123
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectcore biopsyen_US
dc.subjectcorticosteroiden_US
dc.subjectIdiopathic granulomatous mastitisen_US
dc.subjectsurgeryen_US
dc.subjecttreatmenten_US
dc.subjectSurgical-Managementen_US
dc.subjectLobular Mastitisen_US
dc.subjectTherapyen_US
dc.titleManagement of Idiopathic Granulomatous Mastitis Diagnosed by Core Biopsy: A Retrospective Multicenter Studyen_US
dc.typearticleen_US
dc.relation.ispartofBreast Journalen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Genel Cerrahi Ana Bilim Dalıen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Tıbbi Patoloji Ana Bilim Dalıen_US
dc.authorid0000-0002-6396-3168
dc.identifier.volume19en_US
dc.identifier.issue4en_US
dc.identifier.startpage411en_US
dc.identifier.endpage418en_US
dc.institutionauthorGürdal, Sibel Özkan
dc.institutionauthorÖznur, Meltem
dc.institutionauthorSoybir, Gürsel Remzi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorwosidGurdal, Sibel Ozkan/ABA-3882-2020
dc.authorwosidŞen, Ebru/ABB-6373-2021
dc.identifier.wosWOS:000328950400009en_US
dc.identifier.pmid23663101en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster